A pharmacologic option to reduce hospital admissions and relapses of patients with severe mental illness - 08/07/17
Résumé |
Introduction |
Some diseases relapses involve functional impairment that sometimes takes years to recover. We present our experience using long-acting aripiprazole as maintenance therapy in patients diagnosed with psychotic episode, acute mania (bipolar disorder) or personality disorder, who were previously treated with another anti-psychotic.
Aims |
Analyze what treatment were they taking before aripiprazole depot. Determine the number of hospital admissions and relapses before and after long-acting aripiprazole treatment.
Methods |
Descriptive analysis based on a sample of 37 patients, aged 18–65years, treated during one year with anti-psychotics at two community mental health units.
Results |
Reduction of hospitalization average: 0.59/year with non-long-acting-aripiprazol anti-psychotic, 0.18/year with long-acting aripiprazol (66.6%).
Conclusion |
Long-acting aripiprazole appears to reduce the number of hospitalizations and relapses compared to other anti-psychotics. However, the sample size is small and more studies are needed.
Le texte complet de cet article est disponible en PDF.Plan
Vol 41 - N° S
P. S753 - avril 2017 Retour au numéro
Article précédent
- Long acting injectable aripiprazole: An observational study
- N. Garcia, J. Brotons, R. Genoves, J. Martinez-Raga, C. Saez, R. Calabuig
- Tobacco and anti-psychotics side effects
- I. González González, A. Hernández Dorta
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?